USPTO serial 98078291
COMBIGENE
Reviewed by CopyMark Law Group
Status 601
- Filing date
- Status date
- Registration date
- —
- Examiner
- BRYER, BENJAMIN A
- Law office
- TMO LAW OFFICE 112 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with COMBIGENE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Julie A. Greenberg
Julie A. Greenberg FISHMAN STEWART PLLC800 TOWER DRIVE, SUITE 610TROY, MI 48098United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment, prevention, and alleviation of central nervous system disorders, chronic pain, pain relief, epilepsy, Alzheimer's Disease, metabolic diseases, and gene therapy; Medical preparations for the treatment, prevention, and alleviation of central nervous system disorders, chronic pain, pain relief, epilepsy, Alzheimer's Disease, metabolic diseases, and gene therapy | ACTIVE | — |
| 042 | Scientific and technological services, namely, research in the field of medicine and the development of pharmaceuticals, and in the field of identification of drug candidates; Gene therapy research; Scientific preclinical and clinical research in the field of medicine and pharmaceuticals; Conducting preclinical and clinical trials for pharmaceutical products | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 23, 2025 | MAB1 | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT | — |
| Jan 23, 2025 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Jan 22, 2025 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Sep 19, 2024 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Sep 19, 2024 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Jul 16, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 16, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 16, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 19, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 19, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 19, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 19, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 10, 2023 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 9, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 13, 2023 | NWAP | NEW APPLICATION ENTERED | — |